MedTrace Logo

Effects of Oxytocin and Vasopressin on Moral Decision Making

NCT04890470 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2023-09-21

No results posted yet for this study

Summary

To determine whether the neuropeptide oxytocin (OXT) and vassopressin (AVP) influence moral decision making

Conditions

  • Healthy

Interventions

DRUG

Oxytocin

intranasal administration of oxytocin (24 IU)

DRUG

Vasopressin

intranasal administration of vasopressin (20 IU)

DRUG

Placebo

intranasal administration of placebo

Sponsors & Collaborators

  • University of Electronic Science and Technology of China

    lead OTHER

Principal Investigators

  • Keith M. Kendrick · University of Electronic Science and Technology of China

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-02
Primary Completion
2022-12-12
Completion
2022-12-12

Countries

  • China

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04890470 on ClinicalTrials.gov